Navigation Links
Newborns Affected By Antidepressant Intake Of Mothers

Researchers have advised expectant mothers to reduce the intake of anti-depressant drugs, as it is likely to affect the new born with withdrawal symptoms. // The newborn babies of such mothers display symptoms like disturbed sleep, gastrointestinal problems, high-pitched crying, and tremors within 48 hours after birth.

These symptoms are higher in the case of babies of women who had taken higher doses of the medicines. The risk factors were lesser in the case of women who consumed less than 20 milligrams of GlaxoSmithKline’s paroxetine hydrochloride, and higher in the case of dosages of more than 27 milligrams. As many as 30% of the babies who had received exposure to selective serotonin reuptake inhibitors (SSRIs) displayed withdrawal symptoms, and in 13% of the cases the symptoms were seen to be very severe.

The Children's Medical Center of Israel’s Dr. Rachel Levinson-Castiel conducted the research study. The effects of the drugs on children in the long term still remain unknown, even though seizures were reported in a few cases. Other symptoms like jitteriness, low blood sugar, feeding difficulties, and lack of oxygen have also been reported. The children also have to face the consequences of maternal depression during the period of pregnancy. The most frequently used antidepressants are Paxil, Prozac, Celexa, and Zoloft.
'"/>




Page: 1

Related medicine news :

1. Screening Newborns Questioned
2. Cooling Can Reduce The Risk Of Brain Damage In Oxygen Deprived Newborns
3. Newborns Know how to make eye contact
4. New Portable Helmet Scanner To Examine Newborns
5. Use Of Alcohol During Pregnancy Affects Newborns
6. Exposure To Solvents May Harm Pregnant Women And Newborns
7. Pre-gestational Diabetes in Mothers enhances the Risk of Hypocalcaemia in Newborns
8. Newborns Cerebral Palsy Risk Increased By Alzheimers Gene
9. Newborns With Respiratory Distress Potentially Have Rare Genetic Disease
10. Harmful Effects Of Glucocorticoids On Newborns Owing To Prenatal Exposure
11. PFOA and PFOS Detected in Newborns
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th ... Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s CEO, ... The fun run is geared towards children of all ages; it is a non-competitive, ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... “The Journey: ... faced every danger possible to save lost souls in the Philippines. “The Journey: From ... Carole is a dedicated teacher of the Bible. She has taught all ages and ...
(Date:10/12/2017)... , ... October 12, 2017 , ... Planet Fitness, one ... U.S., announced today its plans to open a flagship location in Covington, LA at ... former Rooms To Go store next to Office Depot in the Holiday Square shopping ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... a leader in post-acute health care, have expanded their existing home health joint ... Health. , AccentCare has been operating a joint venture home health company with ...
(Date:10/12/2017)... D.C. (PRWEB) , ... October 12, 2017 , ... Leading ... their peers in Washington, D.C., for the 49th Congress of the International Society ... ., Vice President of the Center for Cancer and Blood Disorders at ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... 2017  Commended for their devotion to personalized service, SMP ... number one in the South Florida Business Journal,s 50 Fastest-Growing ... yearly list, the national specialty pharmacy has found its niche.  ... will soon be honored by SFBJ as the 2017 Power ... Set to receive his award in October, Bardisa said of ...
(Date:9/25/2017)... 2017   Montrium , an industry leader ... the IQPC Trial Master Files & Inspection Readiness ... EastHORN Clinical Services has selected eTMF Connect ... management. EastHORN, a leading European contract research organization ... transparency to enable greater collaboration with sponsors, improve ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, Inc. ... response letter from the U.S. Food and Drug Administration ... of sirukumab for the treatment of moderately to severely ... additional clinical data are needed to further evaluate the ... severely active RA. ...
Breaking Medicine Technology: